Heart Valve

Introduction

The tilting- disc Heart Valve, after successful clinical trials is now commercially available, an indigenously developed remedy which holds a lot of promise for persons with Heart Valve problems especially those suffering from rheumatic heart diseases, for blocked or leaking aortal and mitral passages in the heart. The technology, conceived and crafted by the Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram, was transferred by the funding agency, the National Research Development Corporation (NRDC) to TTK Pharma for commercial exploitation based on its experience in the big?medical devices field. The heart valve's launch is a culmination of more than 15 years of painstaking research and development TTK Pharma is the third company in the world to produce such a heart valve. Artificial heart valves implanted in patients in India (many of them are children who suffer from rheumatic fever) till two years back were imported at a price which rang

Raw Materials:

In the Indian context, the durability of the valve is of paramount importance because the average age of RHO patients is between 20 and 30 years, whereas in the developed countries patients are mostly

For further information please contact :

Director
National Research Development Corporation
20-22, Zamroodpur Community CentreKailash Colony Extension
New Delhi, India
Delhi 110048
Tel: 11 6449401/6460506
Fax: 11 6432121/6449396
Email: info@nrdcindia.com